ITGAX and Zygomycosis: In order to further validate the role of AMs in mucormycosis, we depleted CD11c transgenic mice with the administration of diphtheria toxin (DT), verified selective depletion of CD11c+ cells (Fig. 6g, Supplementary Fig. 11), and assessed the effect on survival following Rhizopus infection.